Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French government's new list of devices paid for separately to DRGs (diagnosis-related groups):

This article was originally published in Clinica

Executive Summary

The French health ministry has updated the list of products that are to be reimbursed separately to medical procedures listed under the diagnosis-related group (DRG) scheme. Normally, medical devices have to be funded from the pot of money allocated to a given medical procedure, but where devices are particularly high-tech and expensive, they are usually funded separately. The new list was published in the Journal officiel of February 28, and is aimed at bringing greater continuity between the public and private sector in terms of products that are reimbursed separately or "en sus", the ministry says. The new list replaces the one that was published on March 2005.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051010

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel